• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Refractory Severe Esophagitis During Durvalumab Therapy in a Patient With Locally Advanced NSCLC.

作者信息

Utsumi Takahiro, Tsubouchi Kazuya, Harada Taishi

机构信息

Department of Respiratory Medicine, Japan Community Health Care Organization Kyushu Hospital, Fukuoka, Japan.

Department of Respiratory Medicine, Japan Community Health Care Organization Kyushu Hospital, Fukuoka, Japan.

出版信息

J Thorac Oncol. 2019 Feb;14(2):e40-e42. doi: 10.1016/j.jtho.2018.10.153.

DOI:10.1016/j.jtho.2018.10.153
PMID:30683299
Abstract
摘要

相似文献

1
Refractory Severe Esophagitis During Durvalumab Therapy in a Patient With Locally Advanced NSCLC.度伐利尤单抗治疗局部晚期非小细胞肺癌患者期间出现的难治性严重食管炎
J Thorac Oncol. 2019 Feb;14(2):e40-e42. doi: 10.1016/j.jtho.2018.10.153.
2
Bronchomediastinal Fistula During Durvalumab Therapy After Chemoradiotherapy in Stage III NSCLC.III期非小细胞肺癌放化疗后使用度伐利尤单抗治疗期间出现支气管纵隔瘘
J Thorac Oncol. 2019 Oct;14(10):1860-1861. doi: 10.1016/j.jtho.2019.06.003. Epub 2019 Jun 13.
3
Three-Arm Randomized Trial of Sodium Alginate for Preventing Radiation-Induced Esophagitis in Locally Advanced Non-Small Cell Lung Cancer Receiving Concurrent Chemoradiotherapy: The OLCSG1401 Study Protocol.海藻酸钠预防局部晚期非小细胞肺癌同步放化疗所致放射性食管炎的三臂随机试验：OLCSG1401研究方案
Clin Lung Cancer. 2017 Mar;18(2):245-249. doi: 10.1016/j.cllc.2016.08.001. Epub 2016 Oct 19.
4
Chemoradiotherapy followed by durvalumab in patients with unresectable advanced non-small cell lung cancer: Management of adverse events.不可切除的晚期非小细胞肺癌患者放化疗序贯度伐利尤单抗治疗：不良反应管理。
Thorac Cancer. 2020 May;11(5):1280-1287. doi: 10.1111/1759-7714.13394. Epub 2020 Mar 11.
5
Predicting factors of symptomatic radiation pneumonitis induced by durvalumab following concurrent chemoradiotherapy in locally advanced non-small cell lung cancer.预测 durvalumab 联合同步放化疗治疗局部晚期非小细胞肺癌后引起的症状性放射性肺炎的因素。
Radiat Oncol. 2022 Jan 15;17(1):7. doi: 10.1186/s13014-021-01979-z.
6
Radiation pneumonitis in lung cancer patients treated with chemoradiation plus durvalumab.放化疗联合度伐利尤单抗治疗肺癌患者的放射性肺炎。
Cancer Med. 2020 Jul;9(13):4622-4631. doi: 10.1002/cam4.3113. Epub 2020 May 6.
7
Patients with unresectable stage III non-small cell lung cancer eligible to receive consolidation therapy with durvalumab in clinical practice based on PACIFIC study criteria.根据 PACIFIC 研究标准，在临床实践中符合接受度伐利尤单抗巩固治疗条件的不可切除 III 期非小细胞肺癌患者。
Respir Investig. 2019 Sep;57(5):466-471. doi: 10.1016/j.resinv.2019.03.011. Epub 2019 May 16.
8
Durvalumab-induced Organizing Pneumonia with a Diffuse Micronodular Pattern in a Patient with Lung Cancer.度伐利尤单抗诱导的肺癌患者出现弥漫性微结节模式的机化性肺炎。
Am J Respir Crit Care Med. 2020 Apr 15;201(8):e52-e53. doi: 10.1164/rccm.201907-1310IM.
9
Predicting Radiation Esophagitis Using 18F-FDG PET During Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer.使用 18F-FDG PET 预测局部晚期非小细胞肺癌放化疗期间的放射性食管炎。
J Thorac Oncol. 2016 Feb;11(2):213-21. doi: 10.1016/j.jtho.2015.10.006. Epub 2015 Dec 22.
10
An esophagus-sparing technique to limit radiation esophagitis in locally advanced non-small cell lung cancer treated by simultaneous integrated boost intensity-modulated radiotherapy and concurrent chemotherapy.一种食管保护技术，用于限制同期整合推量调强放疗和同期化疗治疗局部晚期非小细胞肺癌时的放射性食管炎。
Radiat Oncol. 2018 Jul 17;13(1):130. doi: 10.1186/s13014-018-1073-3.